Valo Therapeutics
valotx.com
Actively hiring
Cell & Gene Therapy
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Grants
$2.4M
1 grant · CORDIS
Backers
1
CDP Venture Capital
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 5%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Apr 2023 | $2.4M | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Valo Therapeutics Oy | ytj.fi |
| Registered | 17 Jun 2016 |
Backed byfrom the funds' portfolios and accelerator catalogs
CDP Venture Capital Similar startupsby what they do, their industry and backers
Top of page About Us Our vision is to create a greener future with sustainable particle technology. CONTACT US Who We Are Naturbeads began…
Profluent is a company founded in 2022 that trains large language models on protein sequences to design new functional proteins. It…
Conception combines stem cell biology and engineering to create new possibilities for having children.
At Jaguar Gene Therapy, we believe in a world where patients and families won’t have to hear those words. Our mission is to accelerate…
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
Search for: At SonomaBio we believe in balance. Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered…
News
Report
Lisata Therapeutics, Valo Therapeutics enter preclinical research collaboration
Lisata Therapeutics (LSTA) and Valo Therapeutics announced a preclinical research collaboration to investigate the benefits of combining Lisata's novel product candidate, certepetide, with ValoTx's platform technology, PeptiCRAd, and a checkpoint inhibito
Read more
Report
ValoTx is not currently hiring
ValoTx is not currently hiring matthew.vaughan Fri, 09/22/2023 - 20:49 div class="clearfix text-formatted field ...
Read more
Report
Valo Therapeutics selects Exothera to develop large-scale oncolytic Adenovirus manufacturing
HELSINKI, Finland, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, today announced it has selected Exothera S.A., a full-service Contract Develo
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Helsinki
Finland
HQ
Helsinki
Viikinkaari 6, 00790 Helsinki, Finland
Financials
Total raised
$2.4M
Latest round
Grant
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2023 | $2.4M | Details |